You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
A history illustrating the complexity of medical decision making and risk. Still the leading cause of death worldwide, heart disease challenges researchers, clinicians, and patients alike. Each day, thousands of patients and their doctors make decisions about coronary angioplasty and bypass surgery. In Broken Hearts David S. Jones sheds light on the nature and quality of those decisions. He describes the debates over what causes heart attacks and the efforts to understand such unforeseen complications of cardiac surgery as depression, mental fog, and stroke. Why do doctors and patients overestimate the effectiveness and underestimate the dangers of medical interventions, especially when doing so may lead to the overuse of medical therapies? To answer this question, Jones explores the history of cardiology and cardiac surgery in the United States and probes the ambiguities and inconsistencies in medical decision making. Based on extensive reviews of medical literature and archives, this historical perspective on medical decision making and risk highlights personal, professional, and community outcomes.
Drugs for the Heart presents highly portable, up-to-date information on every drug class used to treat cardiovascular disease. Drs. Lionel H. Opie and Bernard J. Gersh put the latest dosages, interactions, indications and contraindications, side effects, and more at your fingertips, equipping you to make effective clinical decisions on behalf of your patients Quickly check when to use each drug for any condition with the popular "Which Drug for Which Disease" chapter. Get expert advice from the practice-proven experience of two well-known editors who represent the best possible combination of clinical and research expertise in cardiovascular therapeutics. Expedite your reference with summari...
Now in its fourth edition, the Atlas of Heart Failure provides a comprehensive up-to-date overview of normal cardiac function, the mechanisms of dysfunction in heart failure, and the therapeutic approaches that are available to manage the syndrome. Designed to provide a detailed and comprehensive visual exposition of all aspects of cardiac function and dysfunction, this atlas contains several hundred images, each accompanied by detailed captions, carefully selected by expert authors, and reviewed by the editor.
In its third edition, the Atlas of Heart Failure provides a comprehensive up-to-date overview of normal cardiac function, the mechanisms of dysfunction in heart failure, and the therapeutic approaches that are available to manage the syndrome. Designed to provide a detailed and comprehensive visual exposition of all aspects of cardiac function and dysfunction, this atlas contains several hundred images, each accompanied by detailed captions, carefully selected by expert authors, and reviewed by the editor.
Evidence based Cardiology was first published in 1998 to universal acclaim. Now, with the move towards more patient focused health care and at the same time increased emphasis on health economics, evidence-based practice is a more important force in health care delivery than ever. This new third edition, written by the world’s leading cardiologists, provides graded evidence-based reviews of the major trials together with recommendations for optimum management, and now includes new grading and recommendation methodology. This is a unique book in the field of cardiology, and the largest evidence based clinical cardiology text.
Hypertension is the major cause of left ventricular hypertrophy. While the electrocardiogram is an extremely insensitive measure of anatomic left ven tricular hypertrophy, it provides a time-tested important marker of an adverse cardiovascular outcome. There has been a recent temporal decrease in the incidence of electrocardiographic evidence of L VH even within the hyperten sive population; no doubt this is the result of large antihypertensive treatment experts. Anatomical evidence of left ventricular hypertrophy is best docu mented pre-morbidly using echocardiographic techniques. It therefore ap pears that between 20 and 50 percent of the hypertensive population has left ventricular hypert...
Medical Management of Heart Failure brings together the current knowledge on the medical management of heart failure into one cohesive volume. It includes copious illustrations and photographic material that will explain the techniques and medical management of patients with heart failure in an effective modern format.
Coronary heart disease (CHD) is the leading cause of death worldwide with 3.8 million men and 3.4 million women dying each year. Cardioprotection refers to the prevention of CHD and the clinical improvement in patients suffering from cardiovascular problems. This book focuses on the role of cardioprotection in surgery and the use of pharmacological therapies such as ACE-inhibitors, statins and beta-blockers in order to reduce the myocardial injury sustained by the patient and thesignificant risk of morbidity and mortality. It includes new cardioprotective strategies aimed at improving the clinical outcomes of patients in these settings, as well as current well-established methods for reducing myocardial injury in acute coronary syndrome patients.
This handbook is a ready reference on the theory and operation of modern large, multicenter randomized clinical trials, which have come to be the basis of evidence-based medicine. Written in a concise, engaging style geared to physicians, the book explains the rationale and theoretical foundations for clinical trials, the components of modern clinical trials including their functions and interactions, and practical considerations in the design and implementation of these studies including an introduction to the economics and business aspects.
This South Asia edition of the market-leading cardiac drug resource presents drug and disease scenarios apt for this region. It provides in-depth information on every drug class used to treat heart disease, including the popular "Which Drug for Which Disease" chapter - equipping readers to make effective clinical decisions.. Navigate the latest pharmacologic advances through coverage of the newest drugs and drug classes, as well as all the latest clinical trial results and evidence. . Effectively manage comorbid diseases. . Apply international insights-thanks to new global contributors. . Visualize key pharmacologic and physiologic actions-thanks to dynamic new full-color drawings. • Navigate the latest pharmacologic advances through coverage of the newest drugs and drug classes, as well as all the latest clinical trial results and evidence. • Effectively manage comorbid diseases. • Apply international insights—thanks to new global contributors. • Visualize key pharmacologic and physiologic actions—thanks to dynamic new full-color drawings.